Hepatocellular Carcinoma Consortium

The Hepatocellular Carcinoma (HCC) Laboratory is part of the Mount Sinai Liver Cancer Program, which leads the HCC Genomic Consortium. The Consortium, led by Josep Llovet, MD, conducts translational research in hepatocellular carcinoma.

Members of the HCC Genetic Consortium are:

  • Mount Sinai Liver Cancer Program, with 28 members

  • United States: T. Golub, Y. Hohida, M. Meyerson (Harvard University)

  • Europe:  HCC Translational lab-BCLC

    • J. Bruix (Barcelona)

    • V. Mazzaferro (Milan)

External partners are:

  • George Daley and Ronald DePinho (Harvard University)

  • David Largaespada (University of Minnesota)

  • Massimo Colombo (Milan)

  • Ben Stanger (University of Pennsylvania)

  • Bob Fisher (University of Virginia)

  • HEPTROMIC:  M. Esteller, J. Zuccman-Rossi, L. Zender